Nexalin Technology (NXL) Shares Outstanding (Diluted) (2022 - 2026)
Powered by 
Analysis
Nexalin Technology (NXL) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | 357.30 Mn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | 1.29 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | 386.00 Mn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 577.60 Mn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | 496.20 Mn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | 390.10 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | 97.90 Mn |
| 10 | Nexalin Technology | 3.42 Mn | 2.41 Mn | 8,897.00 | 704,764.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 704,764.00 |
| Mar 31, 2026 | 660,697.00 |
| Dec 31, 2025 | 546,416.00 |
| Sep 30, 2025 | 593,128.00 |
| Jun 30, 2025 | 523,938.00 |
| Mar 31, 2025 | 443,577.00 |
| Dec 31, 2024 | 307,192.00 |
| Sep 30, 2024 | 361,583.00 |
| Jun 30, 2024 | 249,918.00 |
| Mar 31, 2024 | 247,885.00 |
| Dec 31, 2023 | 245,234.00 |
| Sep 30, 2023 | 247,179.00 |
| Jun 30, 2023 | 242,885.00 |
| Mar 31, 2023 | 242,885.00 |
| Dec 31, 2022 | 185,747.00 |
| Sep 30, 2022 | 172,890.00 |
| Jun 30, 2022 | 163,224.00 |